Pharmacists based in GP practices can play an integral role in the prevention of cardiovascular disease, finds new research led by the University of Birmingham.
The study findings, published today (Nov 28 GMT) in the British Journal of Clinical Pharmacology, support the involvement of pharmacists as healthcare providers in managing patients with hypertension, diabetes and high cholesterol.
Pharmacist-led interventions such as patient education, medication review, and medication management can be pivotal in preventing heart-related illnesses, the researchers conclude.
Led by researchers at the University of Birmingham's School of Pharmacy and Institute of Applied Health Research, the team assessed medical literature for relevant randomised controlled clinical trials assessing the effectiveness of pharmacists-led interventions delivered in the general practice in reducing the medical risk factors of cardiovascular events.
They identified 21 trials involving a total 8,933 patients. Pharmacist-led interventions included patient education, medication review and counselling, physical assessment, assessing adherence, lifestyle modification, and medication management such as prescribing, adjusting, monitoring, and administering therapy, and identifying drug-related problems. The most frequently used pharmacist-led interventions were medication review and medication management.
Patients receiving pharmacist-led interventions experienced significant reductions in their systolic blood pressure (by an average of -9.33 mmHg); Hemoglobin A1c, a measure of blood sugar levels (by an average of -0.76%); and LDL-cholesterol (by an average of -15.19 mg/dl). Pharmacist-led interventions also helped patients correctly follow their prescribed medication regimens.
Abdullah Alshehri, of the University of Birmingham, said: "The evidence presented in this review provides an important message to health systems and policy makers regarding the effectiveness of general practice-based pharmacists' interventions.
"The significant reductions in blood pressure, blood glucose, and blood cholesterol reported in this meta-analysis, if sustained in clinical practice, could have significant implications for managing hypertension, diabetes and dyslipidaemia that could prevent cardiovascular morbidity and mortality."
Alshehri noted that the findings support a greater involvement of pharmacists in general practice.
"This will benefit health organisations by providing cost-effective care associated with greater control of patients' conditions and their medications," he said.
###
1. To arrange an interview with the author, please contact Emma McKinney, Media Relations & Communications Manager in the University of Birmingham Press Office, at e.j.mckinney@bham.ac.uk or +44 0121 414 6681.
2. For an embargoed copy of the study please contact: Penny Smith +44 (0) 1243 770448 (UK), newsroom@wiley.com
Notes to Editors:
* Alshehri et al (2019). 'Impact of the Pharmacist-Led Intervention on the Control of Medical Cardiovascular Risk Factors for the Primary Prevention of Cardiovascular Disease in General Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.' British Journal of Clinical Pharmacology. Published Online: November 28, 2019.
* The University of Birmingham is ranked amongst the world's top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.
* The British Journal of Clinical Pharmacology has the primary goal of publishing high quality research papers on all aspects of drug action in humans. The journal has a wide readership, bridging the medical profession, clinical research and the pharmaceutical industry, and is published monthly. It is owned by the British Pharmacological Society and published by Wiley. The journal's current Impact Factor is 3.493 (Thomson Reuters Science Citation Index).
* The British Pharmacological Society is a charity with a mission to promote and advance the whole spectrum of pharmacology. Founded in 1931, it is now a global community at the heart of pharmacology, with over 3,500 members from more than 60 countries worldwide. The Society leads the way in the research and application of pharmacology around the world through its scientific meetings, educational resources and peer-reviewed journals: the British Journal of Clinical Pharmacology, Pharmacology Research & Perspectives, and the British Journal of Pharmacology, which includes the Concise Guide to PHARMACOLOGY, featuring open access overviews of the key properties of over 1,700 human therapeutic targets and their drugs, and links to http://www.guidetopharmacology.org.
* Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at http://www.wiley.com.
Journal
British Journal of Clinical Pharmacology